Methylated arginine derivatives in children and adolescents with chronic kidney disease

Pediatric Nephrology

Volumn 24, Issue 1, 2009, Pages 129-134

  Brooks, Ellen R ^a,b   Langman, Craig B ^a   Wang, Sihe ^a   Price, Heather E ^b   Hodges, Abigail L ^a   Darling, Lara ^a   Yang, Amy Z ^a   Smith, Frederick A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Asymmetric dimethylarginine; Blood pressure; Children; Chronic kidney disease; Hypertension; Symmetric dimethylarginine

Indexed keywords

ARGININE; N(G),N(G) DIMETHYLARGININE;

ADOLESCENT HEALTH; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SLEEP; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; WAKEFULNESS;

ADOLESCENT; ARGININE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; FEMALE; FOOD DEPRIVATION; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; RENAL INSUFFICIENCY, CHRONIC; TANDEM MASS SPECTROMETRY;

EID: 59849120761     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0972-1     Document Type: Article

References (29)

1. Stühlinger M, Conci E, Haubner B, Stocker E, Schwaighofer J, Cooke JP, Tsao P, Pachinger O, Metzler B (2007) Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc Res 75:417-425
2. Busch M, Fleck C, Wolf G, Stein G (2006) Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology. Amino Acids 30:225-232
3. Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E, Honda M, Tokuyama H, Yamamoto T, Kajiya F, Saruta T (2005) Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. Hypertens Res 28:181-189
4. Landray M, Wheeler D, Lip G, Newman D, Blann A, McGlynn F, Ball S, Townend J, Baigent C (2004) Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 43:244-253
5. Thambyrajah J, Landray M, McGlynn F, Jones H, Wheeler D, Townend J (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205-209
6. McDermott J (1976) Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J 154:179-184
7. Bergamini S, Vandelli L, Bellei E, Rota C, Manfredini P, Tomasi A, Albertazzi A, Iannone A (2004) Relationship of asymmetric dimethylarginine to haemodialysis hypotension. Nitric Oxide 11:273-278
8. Nijveldt R, Teerlink T, Siroen M, van Lambalgen AA, Rauwerda JA, van Leeuwen P (2003) The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22:17-22
9. Nijveldt R, van Leeuwen P, Van Guldener C, Stehouwer C, Rauwerda J, Teerlink T (2002) Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 17:1999-2002
10. Carello K, Whitesall S, Lloyd M, Billecke S, D'Alecy L (2006) Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 290:H209-H216
11. Siroen M, van der Sijp J, Teerlink T, van Schaik C, Nijveldt R, van Leeuwen P (2005) The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 41:559-565
12. Mitsnefes M, Knilans T, Mays W, Khoury P, Daniels S (2005) Blood pressure and total peripheral resistance in children with chronic kidney disease. Pediatr Nephrol 20:803-806
13. Goonasekera C, Rees D, Woolard P, Frend A, Shah V, Dillon M (1997) Nitric oxide synthase inhibitors and hypertension in children. J Hypertens 15:901-909
14. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39[suppl 1]:S1-S266
15. Schwartz G, Brion L, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590
16. Wang S, Vicente FB, Miller A, Brooks E, Price H, Smith F (2007) Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 45:1305-1312
17. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2002) Distribution of 24-hour ambulatory blood pressure in children: Normalized reference values and role of body dimensions. J Hypertens 20:1995-2007
18. MacAllister R, Rambousek M, Vallance P, Williams D, Hoffman K, Ritz E (1996) Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11:2449-2452
19. Toth J, Racz A, Kaminski P, Wolin M, Bagi Z, Koller A (2007) Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. Hypertension 49:563-568
20. Yamamizu K, Shinozaki K, Ayajiki K, Gemba M, Okamura T (2007) Oral administration of both tetrahydrobiopterin and L-arginine prevents endothelial dysfunction in rats with chronic renal failure. Cardiovasc Pharmacol 49:131-139
21. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger R, Tripepi G, Sesti G, Zoccali C (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46:518-523
22. Mitsnefes M, Kimball T, Kartal J, Witt S, Glascock B, Khoury P, Daniels S (2006) Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149:671-675
23. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G (2001) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int Suppl 78:S14-S18
24. Schmidt R, Baylis C (2000) Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261-1266
25. Blackwell S, O'Reilly DS, Talwar D (2007) Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma. Eur J Clin Invest 37:364-371
26. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D (2006) Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis. Nephrol Dial Transplant 21:2446-2451
27. de Waard D, Dik P, Lilien M, Kok E, de Jong T (2008) Hypertension is an indication for surgery in children with ureteropelvic junction obstruction. J Urol 179:1976-1978
28. Al Banchaabouchi M, Marescau B, Possemiers I, D'Hooge R, Levillain O, De Deyn P (2000) Ng, NG-dimethylarginine and Ng, NG-dimethylarginine in renal insufficiency. Pflugers Arch 439:524-531
29. Anderstam B, Katzarski K, Bergstrom J (1997) Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8:1437-1442